The MiniMed 670G learns the patient’s insulin needs via an intelligent algorithm and delivers a tailored amount of insulin every five minutes, 24 hours a day, to maximize the time glucose levels are within the target range. The system requires minimal input — patients only need to enter mealtime carbohydrates, accept bolus correction recommendations (a dose of rapid-acting insulin) and, periodically, calibrate the sensor. (read more)
If you have type 2 diabetes, chances are you prick your finger once a day or so to check your blood sugar.
But a growing body of evidence shows that for most type 2 diabetes patients, routinely tracking your blood sugar, or glucose, doesn’t make any difference for your health.
The exception is patients taking insulin or a sulfonylurea drug such as glipizide (which goes by the brand name Glucotrol) or glimepiride (Amaryl), which stimulates beta cells in the pancreas to produce insulin. That’s according to Dr. Jack Ende, president of the American College of Physicians, a professional organization of internal medicine specialists. (read more)
Surgeons or family physicians often encounter wounds of different etiologies on a daily basis. Treating wounds is a challenge as the physicians or surgeons needs to assess wounds accurately, recognize wound related problems and provide interventions such that morbidity reduces. With advanced technology, newer wound care products are helping surgeons to provide optimal benefits to patients. (read more)